
### [MONDO:0009563](http://purl.obolibrary.org/obo/MONDO_0009563)
**Label:** maple syrup urine disease

**Subclasses:** [MONDO:0017052](http://purl.obolibrary.org/obo/MONDO_0017052) (intermediate maple syrup urine disease), 

**Corr. equiv. classes:** [OMIM:615135](http://purl.obolibrary.org/obo/OMIM_615135), [OMIM:248600](http://purl.obolibrary.org/obo/OMIM_248600), [Orphanet:268162](http://www.orpha.net/ORDO/Orphanet_268162), 

**Class expressions from DL-Learner:**

- [HP:0008344](http://purl.obolibrary.org/obo/HP_0008344) (Elevated plasma branched chain amino acids) and (not ([HP:0002795](http://purl.obolibrary.org/obo/HP_0002795) (Functional respiratory abnormality))) 83.33%
- [HP:0008344](http://purl.obolibrary.org/obo/HP_0008344) (Elevated plasma branched chain amino acids) and (not ([HP:0002093](http://purl.obolibrary.org/obo/HP_0002093) (Respiratory insufficiency))) 83.33%
- [HP:0008344](http://purl.obolibrary.org/obo/HP_0008344) (Elevated plasma branched chain amino acids) and (not ([HP:0002086](http://purl.obolibrary.org/obo/HP_0002086) (Abnormality of the respiratory system))) 83.33%
- [HP:0008344](http://purl.obolibrary.org/obo/HP_0008344) (Elevated plasma branched chain amino acids) and (not ([HP:0000600](http://purl.obolibrary.org/obo/HP_0000600) (Abnormality of the pharynx))) 83.33%
- [HP:0008344](http://purl.obolibrary.org/obo/HP_0008344) (Elevated plasma branched chain amino acids) and (not ([HP:0000234](http://purl.obolibrary.org/obo/HP_0000234) (Abnormality of the head))) 83.33%
- [HP:0008344](http://purl.obolibrary.org/obo/HP_0008344) (Elevated plasma branched chain amino acids) and (not ([HP:0000152](http://purl.obolibrary.org/obo/HP_0000152) (Abnormality of head or neck))) 83.33%
- [HP:0008344](http://purl.obolibrary.org/obo/HP_0008344) (Elevated plasma branched chain amino acids) 74.16%
- [HP:0008344](http://purl.obolibrary.org/obo/HP_0008344) (Elevated plasma branched chain amino acids) and [HP:0100547](http://purl.obolibrary.org/obo/HP_0100547) (Abnormality of forebrain morphology) 66.67%
- [HP:0008344](http://purl.obolibrary.org/obo/HP_0008344) (Elevated plasma branched chain amino acids) and [HP:0025032](http://purl.obolibrary.org/obo/HP_0025032) (Abnormality of digestive system physiology) 66.67%
- [HP:0008344](http://purl.obolibrary.org/obo/HP_0008344) (Elevated plasma branched chain amino acids) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 66.67%
- [HP:0008344](http://purl.obolibrary.org/obo/HP_0008344) (Elevated plasma branched chain amino acids) and [HP:0012649](http://purl.obolibrary.org/obo/HP_0012649) (Increased inflammatory response) 66.67%
- [HP:0008344](http://purl.obolibrary.org/obo/HP_0008344) (Elevated plasma branched chain amino acids) and [HP:0012647](http://purl.obolibrary.org/obo/HP_0012647) (Abnormal inflammatory response) 66.67%
- [HP:0008344](http://purl.obolibrary.org/obo/HP_0008344) (Elevated plasma branched chain amino acids) and [HP:0012091](http://purl.obolibrary.org/obo/HP_0012091) (Abnormality of pancreas physiology) 66.67%
- [HP:0008344](http://purl.obolibrary.org/obo/HP_0008344) (Elevated plasma branched chain amino acids) and [HP:0011968](http://purl.obolibrary.org/obo/HP_0011968) (Feeding difficulties) 66.67%
- [HP:0008344](http://purl.obolibrary.org/obo/HP_0008344) (Elevated plasma branched chain amino acids) and [HP:0011458](http://purl.obolibrary.org/obo/HP_0011458) (Abdominal symptom) 66.67%


